• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

挖掘天然提取物的治疗潜力:一项范围综述。

Unlocking the therapeutic potential of natural extract: A scoping review.

作者信息

Reina Bárbara Donadon, Malheiros Samuel Santana, Vieira Sâmmea Martins, Ferreira de Andrade Paula, Dovigo Lívia Nordi

机构信息

Department of Social Dentistry, School of Dentistry, São Paulo State University (UNESP), R. Humaitá, 1680, Araraquara, SP, 14801-385, Brazil.

Department of Prosthodontics and Periodontology, Piracicaba Dental School, Universidade Estadual de Campinas (UNICAMP), Av. Limeira, 901 - Areião, Piracicaba, SP, 13414-903, Brazil.

出版信息

Heliyon. 2024 Nov 20;10(23):e40554. doi: 10.1016/j.heliyon.2024.e40554. eCollection 2024 Dec 15.

DOI:10.1016/j.heliyon.2024.e40554
PMID:39654721
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11625261/
Abstract

DC. (Geraniaceae) is a widely recognized medicinal plant whose natural extract exhibits therapeutic effects through a multi-target approach. Existing literature encompasses investigations of antimicrobial and cellular effects, including clinical trials. A comprehensive review is required to summary the substantial number of published investigations and to grasp the potentialities of this extract. The aim of this scoping review was to provide an overview of the antimicrobial, antiadhesive, immunomodulatory, and respiratory effects of the extract, along with a discussion of its mechanism of action, clinical safety, potential repurposing uses, and areas requiring further investigation. A systematic search of Medline (PubMED) and Scopus databases was conducted using the terms: EPs7630, , . The search process was finished on 5th, June 2024. Two researchers screened titles and abstracts according to the eligibility criteria, which included , , randomized, and non-randomized clinical trials. Out of 4367 publications identified, 134 studies were included in this review. A structured form was applied for data extraction. PRISMA-ScR was used to guide reporting of this review. Most of the studies were conducted , followed by human studies and animal models. The findings demonstrated a strong and broad-spectrum antimicrobial and antiadhesive effect against various bacterial, fungi, and virus species. Additionally, a strong immunomodulatory effect was observed, including the induction of pro-inflammatory cytokines during infection, and modulation of other immune response components. The effects on the respiratory system have been extensively examined, showing remarkable clinical efficacy against both bacterial and viral infections with no significant cytotoxicity or adverse effects. Furthermore, recent research showed an anti-COVID effect by direct antiviral and immunomodulation mechanisms. Nonetheless, the establishment of a concentration protocol to further studies is still challenging due to variations in extract origin, composition and extraction methods. In this sense, the use of a commercial extract such as EPs® 7630 is of great value to facilitate the standardization of the tested protocols. The noteworthy anti-infective potential of extract lies in its multifaceted mechanism of action, which encompasses direct microbicidal effects and modulation of the immune response. These unique properties establish extract as a promising alternative in the war against a wide range of infectious diseases.

摘要

DC.(牻牛儿苗科)是一种广为人知的药用植物,其天然提取物通过多靶点途径发挥治疗作用。现有文献涵盖了对抗菌和细胞效应的研究,包括临床试验。需要进行全面综述,以总结大量已发表的研究,并了解这种提取物的潜力。本范围综述的目的是概述该提取物的抗菌、抗黏附、免疫调节和呼吸作用,并讨论其作用机制、临床安全性、潜在的重新利用用途以及需要进一步研究的领域。使用术语“EPs7630”在Medline(PubMED)和Scopus数据库中进行了系统检索。检索过程于2024年6月5日完成。两名研究人员根据纳入标准筛选标题和摘要,纳入标准包括……、随机和非随机临床试验。在识别出的4367篇出版物中,有134项研究纳入了本综述。采用结构化表格进行数据提取。PRISMA-ScR用于指导本综述的报告。大多数研究是……进行的,其次是人体研究和动物模型。研究结果表明,该提取物对各种细菌、真菌和病毒具有强大的广谱抗菌和抗黏附作用。此外,还观察到了强大的免疫调节作用,包括在感染期间诱导促炎细胞因子,以及调节其他免疫反应成分。对呼吸系统的影响已得到广泛研究,显示出对细菌和病毒感染均具有显著的临床疗效,且无明显细胞毒性或不良反应。此外,最近的研究表明,该提取物通过直接抗病毒和免疫调节机制具有抗新冠病毒作用。然而,由于提取物来源、成分和提取方法的差异,建立进一步研究的浓度方案仍然具有挑战性。从这个意义上说,使用商业提取物如EPs® 7630对于促进测试方案的标准化具有重要价值。该提取物值得注意的抗感染潜力在于其多方面的作用机制,包括直接杀菌作用和免疫反应调节。这些独特的特性使该提取物成为对抗多种传染病的有前途的替代品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/04da8c73392e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/5d884a84786a/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/74241ea0d150/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/9731051d2207/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/8a5332876878/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/ea22005d3ec8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/04da8c73392e/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/5d884a84786a/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/74241ea0d150/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/9731051d2207/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/8a5332876878/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/ea22005d3ec8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99e3/11625261/04da8c73392e/gr5.jpg

相似文献

1
Unlocking the therapeutic potential of natural extract: A scoping review.挖掘天然提取物的治疗潜力:一项范围综述。
Heliyon. 2024 Nov 20;10(23):e40554. doi: 10.1016/j.heliyon.2024.e40554. eCollection 2024 Dec 15.
2
Medicinal properties and conservation of Pelargonium sidoides DC.紫锥菊的药用特性与保护
J Ethnopharmacol. 2014 Mar 14;152(2):243-55. doi: 10.1016/j.jep.2014.01.009. Epub 2014 Jan 21.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children.提取EPs 7630:其治疗儿童急性呼吸道感染的临床疗效和安全性综述。
Int J Gen Med. 2018 Mar 8;11:91-98. doi: 10.2147/IJGM.S154198. eCollection 2018.
5
Evaluation of pharmacodynamic activities of EPs® 7630, a special extract from roots of Pelargonium sidoides, in animals models of cough, secretolytic activity and acute bronchitis.对紫锥菊根的特殊提取物EPs® 7630在咳嗽、溶解分泌物活性及急性支气管炎动物模型中的药效学活性进行评估。
Phytomedicine. 2015 Apr 15;22(4):504-9. doi: 10.1016/j.phymed.2015.03.004. Epub 2015 Mar 20.
6
Pelargonium sidoides extract for treating acute respiratory tract infections.用于治疗急性呼吸道感染的香叶天竺葵提取物。
Cochrane Database Syst Rev. 2013 Oct 22;2013(10):CD006323. doi: 10.1002/14651858.CD006323.pub3.
7
An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach.香叶天竺葵提取物(EPs 7630)可抑制幽门螺杆菌在人胃中的原位黏附。
Phytomedicine. 2007 Apr;14(4):285-8. doi: 10.1016/j.phymed.2006.12.008. Epub 2007 Mar 9.
8
The antifungal and Cryptococcus neoformans virulence attenuating activity of Pelargonium sidoides extracts.南非半边莲提取物的抗真菌和降低新型隐球菌毒力活性。
J Ethnopharmacol. 2019 May 10;235:122-132. doi: 10.1016/j.jep.2019.02.008. Epub 2019 Feb 6.
9
Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs 7630) in the Context of Health Promotion.香叶天竺葵(EPs 7630)在促进健康方面的抗菌、抗病毒和免疫调节活性研究
Pharmaceuticals (Basel). 2011 Oct 10;4(10):1295-1314. doi: 10.3390/ph4101295.
10
Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.香叶天竺葵和肾叶天竺葵迷人的代谢库,草药Umckaloabo的传统和植物药来源。
Phytomedicine. 2007;14 Suppl 6:9-17. doi: 10.1016/j.phymed.2006.11.021. Epub 2006 Dec 22.

引用本文的文献

1
Open, Randomised, Controlled Study to Evaluate the Role of a Dietary Supplement Containing Extract, Honey, Propolis, and Zinc as Adjuvant Treatment in Children with Acute Tonsillopharyngitis.评估含提取物、蜂蜜、蜂胶和锌的膳食补充剂作为急性扁桃体咽炎儿童辅助治疗作用的开放、随机、对照研究。
Children (Basel). 2025 Mar 10;12(3):345. doi: 10.3390/children12030345.
2
Extraction and Processing of Bioactive Phytoconstituents from Widely Used South African Medicinal Plants for the Preparation of Effective Traditional Herbal Medicine Products: A Narrative Review.从广泛使用的南非药用植物中提取和加工生物活性植物成分以制备有效的传统草药产品:一项叙述性综述。
Plants (Basel). 2025 Jan 13;14(2):206. doi: 10.3390/plants14020206.

本文引用的文献

1
Hand, foot, and mouth disease: could EPs® 7630 be a treatment option? A prospective randomized open-label multicenter clinical study.手足口病:EPs® 7630 能否成为一种治疗选择?一项前瞻性随机开放标签多中心临床研究。
Front Pediatr. 2024 May 20;12:1274010. doi: 10.3389/fped.2024.1274010. eCollection 2024.
2
Identifying in-market application of Pelargonium root extract EPs 7630 for the treatment of COVID-19: analysis of pharmacovigilance data.确定天竺葵根提取物EPs 7630在治疗新型冠状病毒肺炎中的市场应用:药物警戒数据分析
Front Pharmacol. 2024 Feb 23;15:1335309. doi: 10.3389/fphar.2024.1335309. eCollection 2024.
3
and effects of root extract EPs 7630 and selected constituents against SARS-CoV-2 B.1, Delta AY.4/AY.117 and Omicron BA.2.
以及根提取物EPs 7630和选定成分对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)B.1、德尔塔AY.4/AY.117和奥密克戎BA.2的作用。
Front Pharmacol. 2023 Jul 26;14:1214351. doi: 10.3389/fphar.2023.1214351. eCollection 2023.
4
EPs 7630 Stimulates Tissue Repair Mechanisms and Modifies Tight Junction Protein Expression in Human Airway Epithelial Cells.EP7630 可刺激组织修复机制并改变人呼吸道上皮细胞的紧密连接蛋白表达。
Int J Mol Sci. 2023 Jul 7;24(13):11230. doi: 10.3390/ijms241311230.
5
Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2.Bi121 对 SARS-CoV-2 不同变体具有显著的广谱抗病毒活性。
Viruses. 2023 May 31;15(6):1299. doi: 10.3390/v15061299.
6
Safety of extract EPs 7630 in young children with acute bronchitis.EPs 7630提取物在患有急性支气管炎的幼儿中的安全性。
Front Pediatr. 2023 Feb 14;11:1107984. doi: 10.3389/fped.2023.1107984. eCollection 2023.
7
Root Extract: Simultaneous HPLC Separation, Determination, and Validation of Selected Biomolecules and Evaluation of SARS-CoV-2 Inhibitory Activity.根提取物:选定生物分子的高效液相色谱同时分离、测定与验证以及新型冠状病毒2抑制活性评估
Pharmaceuticals (Basel). 2022 Sep 23;15(10):1184. doi: 10.3390/ph15101184.
8
The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial.DW1601 治疗急性支气管炎的疗效和安全性:一项多中心、随机、双盲、III 期临床试验。
Korean J Intern Med. 2022 Nov;37(6):1195-1204. doi: 10.3904/kjim.2022.104. Epub 2022 Sep 26.
9
Evaluation of food effects on the pharmacokinetics of and with each bioactive compound berberine and epicatechin after a single oral dose of an expectorant and antitussive agent UI026 in healthy subjects.在健康受试者单次口服祛痰止咳剂UI026后,评估食物对每种生物活性化合物小檗碱和表儿茶素的药代动力学的影响。
Transl Clin Pharmacol. 2022 Mar;30(1):49-56. doi: 10.12793/tcp.2022.30.e3. Epub 2022 Mar 7.
10
Antiviral and Immunomodulatory Effects of Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.根提取物EPs® 7630对感染SARS-CoV-2的人肺细胞的抗病毒和免疫调节作用
Front Pharmacol. 2021 Oct 25;12:757666. doi: 10.3389/fphar.2021.757666. eCollection 2021.